Green light for critical blood drug

AUSTRALIANS battling a killer blood disease will be granted immediate access to life-saving and prolonging treatment after a drug company ended its gridlock with the federal government over funding. FEWER than 30 Australians are known to be living with atypical Haemolytic Uraemic Syndrome (aHUS) - an extremely rare blood disease that attacks the body's vital organs, including the kidneys, heart and brain.
View More/Source Article